EUVIMEDEUVIMED entdecken
Crossref

Cotadutide effect in liver and adipose tissue in obese mice

Ilitch Aquino Marcondes-de-Castro iD, Thamiris Ferreira Oliveira iD, Renata Spezani iD, Thatiany Souza Marinho iD, Luiz Eduardo Macedo Cardoso iD, Marcia Barbosa Aguila iD, Carlos Alberto Mandarim-de-Lacerda iD

Journal of Molecular Endocrinology · 2023

DOI: 10.1530/jme-22-0168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, 2023. Verfasst von Ilitch Aquino Marcondes-de-Castro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, The University of the State of Rio de Jan…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance, Glucose Intolerance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, adipose tissue inflammation, and nonalcoholic fatty liver disease (NAFLD) are associated with insulin resistance and type 2 diabetes (T2D). Cotadutide is a dual agonist GLP-1/glucagon, currently in a preclinical study phase 2 that presents an anti-obesity effect. Diet-induced obese (DIO) C57BL/6 mice were treated for 4 weeks with cotadutide (30 nm/kg once a day at 14:00 h). The study focused on epididymal white adipose tissue (eWAT), liver (NAFLD), inflammation, lipid metabolism, AMP-activated protein kinase (AMPK)/mechanistic target of rapamycin (mTOR) pathways, and the endoplasmic reticulum (ER) stress. As a result, cotadutide controlled weight gain, glucose intolerance, and insulin resistance and showed beneficial effects on plasma markers in DIO mice (triacylglycerol, total cholesterol, alanine aminotransferase, and aspartate aminotransferase, leptin, adiponectin, monocyte chemoattractant protein-1, resistin, interleukin-6, tumor necrosis factor-alpha). Also, cotadutide lessened liver fat accumulation, eWAT proinflammatory markers, and ER stress. In addition, cotadutide improved lipid metabolism genes in eWAT, fatty acid synthase, peroxisome proliferator-activated receptor gamma and mitigates adipocyte hypertrophy and apoptosis. Furthermore, the effects of cotadutide were related to liver AMPK/mTOR pathway and ER stress. In conclusion, cotadutide induces weight loss and treats glucose intolerance and insulin resistance in DIO mice. In addition, cotadutide shows beneficial effects on liver lipid metabolism, mitigating steatosis, inflammation, and ER stress. Besides, in adipocytes, cotadutide decreases hypertrophy and reduces apoptosis. These actions rescuing the AMPK and mTOR pathway, improving lipid metabolism, and lessening NAFLD, inflammation, and ER stress in both eWAT and liver of DIO mice indicate cotadutide as a potentially new pharmacological treatment for T2D and associated obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseInsulin ResistanceGlucose IntoleranceDiabetes Mellitus, Type 2AnimalsMiceMice, ObeseAMP-Activated Protein KinasesMice, Inbred C57BLLiverObesityAdipose TissueInflammationHypertrophyTOR Serine-Threonine KinasesDiet, High-FatPeptides

Stichwörter der Autor:innen

ER stressNAFLDinflammationlipogenesismice

Substanzen

AMP-Activated Protein KinasesTOR Serine-Threonine KinasescotadutidePeptides

Autor:innen und Institutionen

  • Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, The University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Ilitch Aquino Marcondes-de-Castro, Thamiris Ferreira Oliveira, Renata Spezani, Thatiany Souza Marinho, Luiz Eduardo Macedo Cardoso, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda

Zitieren

APA

Marcondes-de-Castro, I. A., Oliveira, T. F., Spezani, R., Marinho, T. S., Cardoso, L. E. M., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2023). Cotadutide effect in liver and adipose tissue in obese mice. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-22-0168

Vancouver

Marcondes-de-Castro IA, Oliveira TF, Spezani R, Marinho TS, Cardoso LEM, Aguila MB, et al. Cotadutide effect in liver and adipose tissue in obese mice. Journal of Molecular Endocrinology. 2023. doi:10.1530/jme-22-0168

BibTeX
@article{MarcondesdeCastro2023,
  author = {Marcondes-de-Castro, Ilitch Aquino and Oliveira, Thamiris Ferreira and Spezani, Renata and Marinho, Thatiany Souza and Cardoso, Luiz Eduardo Macedo and Aguila, Marcia Barbosa and Mandarim-de-Lacerda, Carlos Alberto},
  title = {Cotadutide effect in liver and adipose tissue in obese mice},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  doi = {10.1530/jme-22-0168}
}
Kostenlos starten →